OPERATION FOR HYPERTROPHIC SUBAORTIC STENOSIS IN THE ELDERLY
老年人肥厚性主动脉下狭窄的手术治疗
基本信息
- 批准号:3942867
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The hypothesis tested in this study was that the septal myectomy
operation for palliative treatment of hypertrophic
cardiomyopathy was equally worthwhile in those 65 years and
older as has been shown for younger patients. 52 patients for
whom complete data were available for greater than 5 years after
the operation or until death comprised the study. The mean age
was 69 plus or minus 3 years (range 65-81) 57% of whom were
female. 41 patients had no coronary artery disease (CAD)
requiring surgical palliation. The remainder had CAD. 82 and
95% reduction in peak left ventricular outflow pressure gradients
was achieved in the two groups, respectively. An 8% hospital
mortality and 75 plus or minus 8% 5 year survival was achieved in
those without CAD. Those with CAD had increased hospital
mortality and lower 5 year survival rates. These data support the
clinical impression that older age is not a contraindication to
operative palliation although the presence of significant CAD
increases risk.
在这项研究中检验的假设是,隔肌切除术
肥厚性肥厚症姑息性手术治疗
在这65年里,心肌病同样值得一试
年龄较大的患者表现为较年轻的患者。52名患者接受治疗
他们的完整数据在5年后仍可用
手术或死亡构成了这项研究。平均年龄
69岁正负3岁(65-81岁)其中57%是
女性。41例患者无冠状动脉疾病(CAD)
需要手术姑息。其余患者均患有冠心病。82和
左心室流出道峰压差降低95%
分别在两组中达到。一家8%的医院
死亡率和75%的5年生存率为8%或8%
那些没有CAD的。那些患有冠心病的人增加了住院时间
死亡率和较低的5年生存率。这些数据支持
临床印象中年龄较大并不是
手术姑息,尽管存在显著的冠心病
增加风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M M COOPER其他文献
M M COOPER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M M COOPER', 18)}}的其他基金
OPERATION FOR HYPERTROPHIC SUBAORTIC STENOSIS IN THE ELDERLY
老年人肥厚性主动脉下狭窄的手术治疗
- 批准号:
3966648 - 财政年份:
- 资助金额:
-- - 项目类别:
EFFECT OF LEFT VENTRICULAR SEPTAL MYECTOMY ON CONCURRENT MITRAL REGURGITATION
左心室间隔切除术对并发二尖瓣反流的影响
- 批准号:
3920089 - 财政年份:
- 资助金额:
-- - 项目类别:
USE OF MONOCLONAL ANTI-TAC ANTIBODY AS IMMUNOSUPPRESSION FOR CARDIAC XENOGRAFTS
使用单克隆抗 TAC 抗体作为心脏异种移植物的免疫抑制
- 批准号:
3920090 - 财政年份:
- 资助金额:
-- - 项目类别:
USE OF MONOCLONAL ANTI-TAC ANTIBODY AS IMMUNOSUPPRESSION FOR CARDIAC XENOGRAFTS
使用单克隆抗 TAC 抗体作为心脏异种移植物的免疫抑制
- 批准号:
3942873 - 财政年份:
- 资助金额:
-- - 项目类别:
EFFECT OF LEFT VENTRICULAR SEPTAL MYECTOMY ON CONCURRENT MITRAL REGURGITATION
左心室间隔切除术对并发二尖瓣反流的影响
- 批准号:
3942872 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Role of clonal hematopoiesis of indeterminate potential in development of calcific aortic valve stenosis
不确定潜能克隆造血在钙化性主动脉瓣狭窄发展中的作用
- 批准号:
23K07522 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of rare genetic variants to aortic valve stenosis in Quebec French-Canadians
罕见遗传变异对魁北克法裔加拿大人主动脉瓣狭窄的影响
- 批准号:
493134 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Comprehensive exploratory study on aortic valve stenosis with activated macrophages as the main axis
以活化巨噬细胞为主轴的主动脉瓣狭窄综合探索性研究
- 批准号:
23K07512 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of an Artificial Intelligence Model for Evaluation of Echocardiographic Severity in Aortic Valve Stenosis
开发用于评估主动脉瓣狭窄超声心动图严重程度的人工智能模型
- 批准号:
23K15111 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Imaging Substudy of the BEST Trial: Balloon-Expandable versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis
最佳试验的影像学子研究:球囊扩张式与自扩张式经导管心脏瓣膜治疗症状性自体主动脉瓣狭窄
- 批准号:
460606 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Operating Grants
Using Claims-Based Signatures of Frailty to Support Individualized Treatment of Aortic Valve Stenosis and Coronary Artery Disease
使用基于索赔的虚弱特征来支持主动脉瓣狭窄和冠状动脉疾病的个体化治疗
- 批准号:
10363612 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Using Claims-Based Signatures of Frailty to Support Individualized Treatment of Aortic Valve Stenosis and Coronary Artery Disease
使用基于索赔的虚弱特征来支持主动脉瓣狭窄和冠状动脉疾病的个体化治疗
- 批准号:
10545062 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Investigating the role of CaV1.2 in aortic valve stenosis
研究 CaV1.2 在主动脉瓣狭窄中的作用
- 批准号:
10421276 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Investigating the role of CaV1.2 in aortic valve stenosis
研究 CaV1.2 在主动脉瓣狭窄中的作用
- 批准号:
10132390 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Investigating the role of CaV1.2 in aortic valve stenosis
研究 CaV1.2 在主动脉瓣狭窄中的作用
- 批准号:
10611495 - 财政年份:2020
- 资助金额:
-- - 项目类别:














{{item.name}}会员




